[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355611-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355611-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","stromal-hypoxia-and-autophagy-signatures-as-indicators-of-pathologic-response-in-triple-negative-breast-cancer","Stromal hypoxia and autophagy signatures as indicators of pathologic response in triple-negative breast cancer","","Triple-negative breast cancer (TNBC) remains aggressive and lacks clear therapeutic targets, making prediction of neoadjuvant chemotherapy (NACT) response a critical unmet need. Hypoxia-driven biology, autophagy, apoptosis, and translational stress are implicated in progression and treatment resistance, yet their combined predictive value is unclear. This study evaluates hypoxia marker HIF-1α, autophagy markers (Beclin-1, LC3A), apoptosis marker (Bcl-2), and translational stress marker (eIF2α) for associations with clinicopathologic features, Miller–Payne and Residual Cancer Burden response, and survival in TNBC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/stromal-hypoxia-and-autophagy-signatures-as-indicators-of-pathologic-response-in-triple-negative-breast-cancer/355611/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/stromal-hypoxia-and-autophagy-signatures-as-indicators-of-pathologic-response-in-triple-negative-breast-cancer/355611.png","ImageObject",300,407,{"name":42,"@type":43},"วิน","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which biomarkers were investigated for predicting neoadjuvant chemotherapy response in TNBC?","Question",{"text":63,"@type":64},"The study examined hypoxia-related HIF-1α, autophagy-related Beclin-1 and LC3A, apoptosis-related Bcl-2, and translational stress-related eIF2α.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was pathological response to NACT assessed?",{"text":68,"@type":64},"Pathological response was evaluated using the Miller–Payne (MP) system and Residual Cancer Burden (RCB) classification.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main predictive findings for treatment response and survival?",{"text":72,"@type":64},"Beclin-1 expression and stromal HIF-1α were significantly associated with better MP response and favorable outcome patterns, while none of the biomarkers predicted overall or disease-free survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355611,1790639271,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","Mavili etal. BMC Cancer (2026) 26:552 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15860-3](https://doi.org/10.1186/s12885-026-15860-3)  \nRESEARCH Open Access  \nStromal hypoxia and autophagy signatures  as indicators of pathologic response in triplenegative breast cancer  \nHanife Seda Mavili1*, Ömer Atmış1, Fatma Seher Pehlivan1, Ferhat Ekinci2, Buse Gündaş Bektaş1, Emine Bihter Eniseler2 and AyçaTan1  \nAbstract  \nBackground Triple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic targets. Hypoxia, autophagy, apoptosis, and translational stress are key biological processes involved in tumor progression and treatment resistance, but their predictive value for neoadjuvant chemotherapy (NACT) response remains unclear. This study aimed to investigate the association of hypoxia-related (HIF-1α), autophagy-related (Beclin-1, LC3A), apoptosisrelated (Bcl-2), and translational stress–related (eIF2α) markers with response to NACT inTNBC, and to explore their relationships with clinicopathological features and survival outcomes.  \nMethods Fifty-seven patients with TNBC who received NACT were retrospectively analyzed. Pretreatment tru-cut biopsy specimens were immunohistochemically stained for HIF-1α, Beclin-1, LC3A, Bcl-2, and eIF2α . Marker expression was evaluated using two semi-quantitative scoring systems. Pathological response was assessed using the Miller– Payne (MP) system and Residual Cancer Burden (RCB) classification. Associations with clinicopathological parameters, Miller–Payne (MP) and Residual Cancer Burden (RCB) systems, post-NACT morphological features, and survival were assessed using Spearman correlation, Kruskal–Wallis test, ROC analysis, chi-square tests, and Kaplan–Meier survival. Results Beclin-1 expression was significantly associated with higher MP response (p = 0 . 019) and demonstrated meaningful discriminatory ability for predicting good response (p = 0 . 02) . HIF-1α showed a weak positive correlation with MP score (p = 0 . 042) and a borderline predictive trend (p = 0 . 078) . LC3A, Bcl-2, and eIF2α did not show significant predictive value for treatment response. Stromal HIF-1α expression was significantly associated with increased stromallymphocytic infiltration (p = 0 . 009), reduced residual invasive tumor following NACT (p = 0 . 039), and increased foamy/ hemosiderin-laden macrophages (p = 0 .020–0. 039), indicating hypoxia-related stromal remodeling. None of the biomarkers predicted overall or disease-free survival, whereas high MP response and RCB 0–1 were strong predictors of favorable outcomes.  \nConclusions Beclin-1 and stromal HIF-1α may serve as useful predictors of pathological response to NACT inTNBC, reflecting the biological impact of autophagy activation and hypoxia-mediated stromal modulation. Incorporation of these markers into pretreatment evaluation may improve response stratification inTNBC.  \n*Correspondence:  \nHanife Seda Mavili[sedaa_ugur@hotmail.com](sedaa_ugur@hotmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission","cbCaicgditrYzGDW","https://ap.wps.com/l/cbCaicgditrYzGDW","pdf",1811798,12,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"Which biomarkers were investigated for predicting neoadjuvant chemotherapy response in TNBC?\",\"answer\":\"The study examined hypoxia-related HIF-1α, autophagy-related Beclin-1 and LC3A, apoptosis-related Bcl-2, and translational stress-related eIF2α.\"},{\"question\":\"How was pathological response to NACT assessed?\",\"answer\":\"Pathological response was evaluated using the Miller–Payne (MP) system and Residual Cancer Burden (RCB) classification.\"},{\"question\":\"What were the main predictive findings for treatment response and survival?\",\"answer\":\"Beclin-1 expression and stromal HIF-1α were significantly associated with better MP response and favorable outcome patterns, while none of the biomarkers predicted overall or disease-free survival.\"}]","Stromal hypoxia and autophagy signatures as indicators of pathologic response in triple-negative breast cancer | PDF",1790120153,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8e0d100a3542b601a738c76d51936e3.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4f49393a5ca59eeacfcb9bd0567ca8a.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b04337cfd436ecd82896115122e6152.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce88dbbb5fa90915c79a20c6c5ca34a4.webp",980,1306]